Conference Coverage
Videos
NewsNetwork
OncLive® TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
OncLive Global Expo
Giants of Cancer Care
Join Our Community

Don't miss real-time top news, insights, and interviews with the experts direct from the conference floor in Chicago. Sign up now to be reminded to tune in to OncLive News Network: On Location in Chicago.

SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology®
Neoadjuvant HER2+
More >>
<< View More Conferences

2019 State of the Science Summit on Genitourinary Cancers in Needham

Oncology Conference Multimedia
View more videos >>
Dr. McGregor on the Future of Cabozantinib in RCC
Dr. McGregor on the Future of Cabozantinib in RCC
Dr. Sonpavde on Key Data With Immunotherapy in Metastatic Bladder Cancer
Dr. Sonpavde on Key Data With Immunotherapy in Metastatic Bladder Cancer
Dr. McGregor on the Utility of Axitinib/Avelumab in Advanced RCC
Dr. McGregor on the Utility of Axitinib/Avelumab in Advanced RCC
Oncology Conference Articles
RCC Paradigm Continues to Rapidly Develop With TKI/IO Combos
RCC Paradigm Continues to Rapidly Develop With TKI/IO Combos
Bradley McGregor, MD, speaks about the various data that have emerged in renal cell carcinoma with combinations of immunotherapy, TKIs, and how he chooses between the available treatments for his patients.
ADT-Associated Cardiac AEs in Prostate Cancer Require Multidisciplinary Care
ADT-Associated Cardiac AEs in Prostate Cancer Require Multidisciplinary Care
Pei-Chun McGregor, MD, discusses where future research with androgen deprivation therapy-associated adverse events is headed, and called for multidisciplinary care for patients receiving this approach.
Rapid Advances Underscore Significance of Patient Selection in Metastatic Prostate Cancer
Rapid Advances Underscore Significance of Patient Selection in Metastatic Prostate Cancer
Atish D. Choudhury, MD, PhD, details the advances in metastatic prostate cancer in light of updated analyses from several clinical trials and forthcoming research in the field.
Next Steps in Bladder Cancer Include Chemoimmunotherapy, Targeted Agents, and ADCs
Next Steps in Bladder Cancer Include Chemoimmunotherapy, Targeted Agents, and ADCs
Guru Sonpavde, MD, discusses the current use of immunotherapy and the numerous strategies in development in bladder cancer. 
Pivotal Studies Pave Way for Nonmetastatic CRPC Treatment
Pivotal Studies Pave Way for Nonmetastatic CRPC Treatment
Richard (Rick) JaeBong Lee, MD, PhD, discusses the differences between second-generation targeted antiandrogens and highlights potential factors to consider in terms of selection.
Novel Imaging Techniques Emerge in Prostate Cancer
Novel Imaging Techniques Emerge in Prostate Cancer
David J. Einstein, MD, discusses newer imaging techniques and overall progress in the treatment of patients with nonmetastatic hormone-sensitive prostate cancer.
Publication Bottom Border
Border Publication
 
x